Assignee
BIOPHARMX INC
US·9 granted patents·6 pending applications·56 citations·filing 2014–2019
Top patents by PatentIndex Score
15 records- 0198US9474720B2Dosage form comprising an active ingredient and a plurality of solid porous microcarriersBIOPHARMX INC·Filed 2014·Granted Oct 25, 2016·37 cites·20 claims
- 0294US10159686B2Dosage form comprising an active ingredient and a plurality of solid porous microcarriersBIOPHARMX INC·Filed 2018·Granted Dec 25, 2018·5 cites·24 claims
- 0387US10391108B2Pharmaceutical tetracycline composition for dermatological useBIOPHARMX INC·Filed 2018·Granted Aug 27, 2019·7 cites·32 claims
- 0486US10391121B2Magnesium chloride composition for dermatological useBIOPHARMX INC·Filed 2018·Granted Aug 27, 2019·2 cites·19 claims
- 0582US9642867B2Dosage form comprising an active ingredient and a plurality of solid porous microcarriersBIOPHARMX INC·Filed 2016·Granted May 9, 2017·1 cites·19 claims
- 0680US9918998B2Pharmaceutical tetracycline composition for dermatological useBIOPHARMX INC·Filed 2016·Granted Mar 20, 2018·3 cites·42 claims
- 0777US9901586B2Dosage form comprising an active ingredient and a plurality of solid porous microcarriersBIOPHARMX INC·Filed 2015·Granted Feb 27, 2018·1 cites·17 claims
- 0868US10034899B2Solid oral dosage form for breast symptomsBIOPHARMX INC·Filed 2014·Granted Jul 31, 2018·0 cites·44 claims
- 0962US2019328775A1Magnesium chloride composition for dermatological useBIOPHARMX INC·Filed 2019·Application pending·0 cites
- 1061US10881672B2Pharmaceutical tetracycline composition for dermatological useBIOPHARMX INC·Filed 2019·Granted Jan 5, 2021·0 cites·19 claims
- 1158US2018296594A1Solid oral dosage form for breast symptomsBIOPHARMX INC·Filed 2018·Application pending·0 cites
- 1247US2019255078A1Topical compositions with stable solubilized selective retinoids and/or tetracycline-class antibioticsBIOPHARMX INC·Filed 2019·Application pending·0 cites
- 1343US2020129495A1Ebastine topical compositionBIOPHARMX INC·Filed 2018·Application pending·0 cites
- 1442US2017304359A1Oral iodine dosage formBIOPHARMX INC·Filed 2017·Application pending·0 cites
- 1538US2016287615A1Novel encapsulation of fluorescent, photo-sensitive, or oxygen-sensitive active ingredient for topical applicationBIOPHARMX INC·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →